Status:
COMPLETED
Investigation of Cancer Cell Extravasation Through mRNA Analysis of Organ-specific Endothelial Cells and Microfluidics
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Breast Cancer Metastatic
Eligibility:
All Genders
18-65 years
Brief Summary
The project aims at unraveling the role of organ-specific endothelia mediating the preferential metastasisation of breast cancer cells to bone by using a multi-faceted approach, integrating microfluid...
Detailed Description
In particular, the main aim of the study will be to highlight differences between bone and skeletal muscle microenvironments, which are respectively preferential and non-preferential metastasisation s...
Eligibility Criteria
Inclusion
- age between 18-65 years
- patients undergoing cruciate ligament surgery or hip arthroplasty
- subscription of informed consent
Exclusion
- \- HIV, HCV, HBV, TPHA viral
Key Trial Info
Start Date :
June 6 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04047459
Start Date
June 6 2016
End Date
May 31 2018
Last Update
August 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Galeazzi Orthopedic Hospital
Milan, Italy, 20161